Lessons learned from the Saltz and Mayo Clinic regimens.
Chu
Edward
E
Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000401:mortality; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000009:adverse effects; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin